A Study For Treatment of Paroxysmal Atrial Fibrillation (PAF) With the OMNYPULSE Catheter and the TRUPULSE Generator
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 188 participants.
Also called NCT05971693
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 188 participants
- Sponsor
- Registry
-
NCT05971693
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Belgium, Canada, Croatia, Czechia, Germany, Italy, Lithuania, Netherlands
- Registry status
- Completed
Technical summary
Registry record NCT05971693. Allocation not applicable; no masking; primary purpose treatment. Start 2023-09-12 (actual); primary completion 2024-12-10 (actual). Results posted on 2026-03-25.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study For Treatment of Paroxysmal Atrial Fibrillation (PAF) With the OMNYPULSE Catheter and the TRUPULSE Generator
- Acronym
- Omny-IRE
- Condition
- Atrial Fibrillation
- Intervention (Device)
- OMNYPULSE Bi-Directional Catheter with TRUPULSE Generator
- Lead sponsor
- Biosense Webster, Inc.
Record details
- Record id
cardio:ct-nct05971693- Content hash
e6280cafb3936fe8dbf9aa01eb45375a576661f47d602550dd16a0a6f5063e6b